Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial

Ulrik Pedersen-Bjergaard; Rikke M. Agesen; Julie M. B. Brosen; Amra C. Alibegovic; Henrik U. Andersen; Henning Beck-Nielsen; Peter Gustenhoff; Troels K. Hansen; Christoffer Hedetoft; Tonny J. Jensen; Claus B. Juhl; Andreas K. Jensen; Susanne S. Lerche; Kirsten Norgaard; Hans-Henrik Parving; Anne L. Sørensen; Lise Tarnow; Birger Thorsteinsson

doi:10.1111/dom.14574

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial

Ulrik Pedersen-Bjergaard, Rikke M. Agesen, Julie M. B. Brosen, Amra C. Alibegovic, Henrik U. Andersen, Henning Beck-Nielsen, Peter Gustenhoff, Troels K. Hansen, Christoffer Hedetoft, Tonny J. Jensen, Claus B. Juhl, Andreas K. Jensen, Susanne S. Lerche, Kirsten Norgaard, Hans-Henrik Parving, Anne L. Sørensen, Lise Tarnow, Birger Thorsteinsson

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

11 Citationer (Scopus)

26 Downloads (Pure)

Originalsprog	Engelsk
Tidsskrift	Diabetes, Obesity and Metabolism
Vol/bind	24
Udgave nummer	2
Sider (fra-til)	257-267
Antal sider	11
ISSN	1462-8902
DOI	https://doi.org/10.1111/dom.14574
Status	Udgivet - 2022

Adgang til dokumentet

10.1111/dom.14574Licens: CC BY

FulltextForlagets udgivne version, 1,19 MBLicens: CC BY

Citationsformater

Pedersen-Bjergaard, U., Agesen, R. M., Brosen, J. M. B., Alibegovic, A. C., Andersen, H. U., Beck-Nielsen, H., Gustenhoff, P., Hansen, T. K., Hedetoft, C., Jensen, T. J., Juhl, C. B., Jensen, A. K., Lerche, S. S., Norgaard, K., Parving, H.-H., Sørensen, A. L., Tarnow, L., & Thorsteinsson, B. (2022). Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial. Diabetes, Obesity and Metabolism, 24(2), 257-267. https://doi.org/10.1111/dom.14574

Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial. / Pedersen-Bjergaard, Ulrik; Agesen, Rikke M.; Brosen, Julie M. B. et al.
I: Diabetes, Obesity and Metabolism, Bind 24, Nr. 2, 2022, s. 257-267.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Pedersen-Bjergaard, U, Agesen, RM, Brosen, JMB, Alibegovic, AC, Andersen, HU, Beck-Nielsen, H, Gustenhoff, P, Hansen, TK, Hedetoft, C, Jensen, TJ, Juhl, CB, Jensen, AK, Lerche, SS, Norgaard, K, Parving, H-H, Sørensen, AL, Tarnow, L & Thorsteinsson, B 2022, 'Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial', Diabetes, Obesity and Metabolism, bind 24, nr. 2, s. 257-267. https://doi.org/10.1111/dom.14574

Pedersen-Bjergaard U, Agesen RM, Brosen JMB, Alibegovic AC, Andersen HU, Beck-Nielsen H et al. Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial. Diabetes, Obesity and Metabolism. 2022;24(2):257-267. doi: 10.1111/dom.14574

@article{31c2425223fc4087a99c07e48e6137b6,

title = "Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open-label, crossover trial",

keywords = "basal insulin, hypoglycaemia, insulin analogues, phase IV study, randomized trial, type 1 diabetes",

author = "Ulrik Pedersen-Bjergaard and Agesen, {Rikke M.} and Brosen, {Julie M. B.} and Alibegovic, {Amra C.} and Andersen, {Henrik U.} and Henning Beck-Nielsen and Peter Gustenhoff and Hansen, {Troels K.} and Christoffer Hedetoft and Jensen, {Tonny J.} and Juhl, {Claus B.} and Jensen, {Andreas K.} and Lerche, {Susanne S.} and Kirsten Norgaard and Hans-Henrik Parving and S{\o}rensen, {Anne L.} and Lise Tarnow and Birger Thorsteinsson",

year = "2022",

doi = "10.1111/dom.14574",

language = "English",

volume = "24",

pages = "257--267",

journal = "Diabetes, Obesity and Metabolism",

issn = "1462-8902",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia

T2 - The HypoDeg randomized, controlled, open-label, crossover trial

AU - Pedersen-Bjergaard, Ulrik

AU - Agesen, Rikke M.

AU - Brosen, Julie M. B.

AU - Alibegovic, Amra C.

AU - Andersen, Henrik U.

AU - Beck-Nielsen, Henning

AU - Gustenhoff, Peter

AU - Hansen, Troels K.

AU - Hedetoft, Christoffer

AU - Jensen, Tonny J.

AU - Juhl, Claus B.

AU - Jensen, Andreas K.

AU - Lerche, Susanne S.

AU - Norgaard, Kirsten

AU - Parving, Hans-Henrik

AU - Sørensen, Anne L.

AU - Tarnow, Lise

AU - Thorsteinsson, Birger

PY - 2022

Y1 - 2022

KW - basal insulin

KW - hypoglycaemia

KW - insulin analogues

KW - phase IV study

KW - randomized trial

KW - type 1 diabetes

U2 - 10.1111/dom.14574

DO - 10.1111/dom.14574

M3 - Journal article

C2 - 34643020

SN - 1462-8902

VL - 24

SP - 257

EP - 267

JO - Diabetes, Obesity and Metabolism

JF - Diabetes, Obesity and Metabolism

IS - 2

ER -